Clinical Trials Directory

Trials / Sponsors / Valerio Therapeutics

Valerio Therapeutics

Industry · 25 registered clinical trials.

StatusTrialPhaseStarted
TerminatedA Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors
Advanced or Metastatic Solid Tumors, Breast Cancer, Recurrent Ovarian Cancer
Phase 1 / Phase 22024-01-10
CompletedStudy to Assess Safety and Efficacy of AsiDNA in Combination with Olaparib in Participants with Recurrent Soli
Metastatic Castration-resistant Prostate Cancer, Recurrent Epithelial Ovarian Cancer, Breast Cancer
Phase 1 / Phase 22023-02-20
CompletedAsiDNA (a DNA Repair Inhibitor) Administered IntraVenously in Advanced Solid Tumors
Advanced Cancer
Phase 12018-04-05
CompletedPhase 1 PK, Bioavailability, Safety Study of Clonidine MBT w Catapres in Healthy Volunteers
Healthy
Phase 12015-09-01
CompletedEfficacy and Safety Doxorubicin Transdrug Study in Patients Suffering From Advanced Hepatocellular Carcinoma
Carcinoma, Hepatocellular
Phase 32012-06-01
WithdrawnSafety and Efficacy of Intramuscular Electrotransfer of Plasmid AMEP in Patients Suffering From Advanced or Me
Melanoma
Phase 1 / Phase 22012-06-01
TerminatedSafety and Efficacy Study of Electrotransfer of Plasmid AMEP to Treat Advanced or Metastatic Melanoma
Melanoma
Phase 12010-07-01
CompletedEfficacy and Safety Study of Clonidine Lauriad® to Treat Oral Mucositis
Oral Mucositis
Phase 22010-04-01
CompletedBelinostat, Carboplatin and Paclitaxel (BelCaP) Compared to Carboplatin and Paclitaxel in Patients With Cancer
Carcinoma of Unknown Primary
Phase 22009-02-01
CompletedTrial of PXD101 (Belinostat) in Combination With Idarubicin to Treat AML Not Suitable for Standard Intensive T
Acute Myeloid Leukemia
Phase 1 / Phase 22007-08-01
CompletedPhase 3 Clinical Study for the Treatment of Cold Sore
Herpes Labialis
Phase 32007-05-01
TerminatedA Phase II Study of Belinostat in Combination With Bortezomib in Patients With Relapsed, Refractory Multiple M
Multiple Myeloma
Phase 22007-03-01
CompletedA Phase I Dose Finding Study of APO010 in Patients With Solid Tumors
Cancer
Phase 12007-02-01
CompletedA Phase I/II Study to Assess the Safety and Tolerability of APO866 for the Treatment of Refractory B-CLL
B-cell Chronic Lymphocytic Leukemia
Phase 1 / Phase 22007-02-01
CompletedA Study of APO866 for the Treatment of Cutaneous T-cell Lymphoma
Cutaneous T-cell Lymphoma
Phase 22007-02-01
CompletedA Phase I/II Clinical Trial of PXD101 in Combination With Doxorubicin in Patients With Soft Tissue Sarcomas
Dose Escalation: Solid Tumors, MTD: Soft Tissue Sarcomas
Phase 1 / Phase 22006-12-01
CompletedA Study to Assess APO866 for the Treatment of Advanced Melanoma
Melanoma
Phase 22006-07-01
CompletedEfficacy and Safety Study of Miconazole Lauriad to Treat Oropharyngeal Candidiasis in HIV Patients
HIV Infections
Phase 32006-07-01
CompletedStudy of Oral PXD101 in Patients With Advanced Solid Tumors or Lymphoma
Solid Tumor, Lymphoma
Phase 12006-06-01
TerminatedA Phase II Clinical Trial of PXD101 in Patients With Recurrent or Refractory Cutaneous and Peripheral T-Cell L
Cutaneous T-Cell Lymphoma, Peripheral T-Cell Lymphoma, Non-Hodgkin's Lymphoma
Phase 22006-01-01
CompletedStudy of PXD101 Alone and in Combination With 5-Fluorouracil (5-FU) in Patients With Advanced Solid Tumors
Tumor
Phase 12005-09-01
CompletedA Study of Belinostat + Carboplatin or Paclitaxel or Both in Patients With Ovarian Cancer in Need of Relapse T
Ovarian Cancer, Epithelial Ovarian Cancer, Fallopian Tube Cancer
Phase 1 / Phase 22005-08-01
CompletedClinical Trial of PXD101 in Patients With Advanced Multiple Myeloma
Multiple Myeloma
Phase 22005-01-01
CompletedA Clinical Trial on Topotect® (Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracyclines
Extravasation
Phase 2 / Phase 32002-04-01
CompletedEfficacy of TopotectTM (Dexrazoxane) for Accidental Extravasation of Anthracyclines
Anthracycline Extravasation
Phase 2 / Phase 32001-06-01